Institute of Pharmacology, University of Marburg, Marburg, Germany.
PLoS One. 2013 Aug 2;8(8):e69947. doi: 10.1371/journal.pone.0069947. Print 2013.
We have recently characterized SCAI (Suppressor of Cancer Cell Invasion), a transcriptional modulator regulating cancer cell motility through suppression of MAL/SRF dependent gene transcription. We show here that SCAI is expressed in a wide range of normal human tissues and its expression is diminished in a large array of primary human breast cancer samples indicating that SCAI expression might be linked to the etiology of human cancer. To establish a functional link between SCAI and tumorigenesis we performed affinity columns to identify SCAI-interacting proteins. Our data show that SCAI interacts with the tumor suppressing SWI/SNF chromatin remodeling complex to promote changes in gene expression and the invasive capacities of human tumor cells. Moreover our data implicate a functional hierarchy between SCAI and BRM, since SCAI function is abrogated in the absence of BRM expression.
我们最近对 SCAI(癌细胞侵袭抑制因子)进行了特征描述,它是一种转录调节剂,通过抑制 MAL/SRF 依赖性基因转录来调节癌细胞的运动性。我们在这里表明,SCAI 在广泛的正常人类组织中表达,并且在大量原发性人类乳腺癌样本中表达减少,这表明 SCAI 表达可能与人类癌症的病因有关。为了在 SCAI 和肿瘤发生之间建立功能联系,我们进行了亲和柱实验以鉴定 SCAI 相互作用蛋白。我们的数据表明,SCAI 与肿瘤抑制性 SWI/SNF 染色质重塑复合物相互作用,以促进人类肿瘤细胞的基因表达和侵袭能力的变化。此外,我们的数据表明 SCAI 和 BRM 之间存在功能层次关系,因为在缺乏 BRM 表达的情况下,SCAI 的功能被废除。